Efficacy of lateral lymph node dissection for local control of rectal cancer: A multicenter study

被引:0
|
作者
Tanaka, Yusuke [1 ]
Hino, Hitoshi [1 ,9 ]
Shiomi, Akio [1 ]
Uehara, Kay [2 ]
Watanabe, Jun [3 ]
Nishikawa, Takeshi [4 ]
Ueno, Hideki [5 ]
Kinugasa, Yusuke [6 ]
Kawai, Kazushige [7 ]
Ajioka, Yoichi [8 ]
机构
[1] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[2] Nippon Med Sch, Div Gastrointestinal & Hepatobiliary Pancreat Surg, Tokyo, Japan
[3] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Dept Surg, Yokohama, Japan
[4] Saitama Canc Ctr, Div Gastroenterol Surg, Ina, Japan
[5] Natl Def Med Coll, Dept Surg, Tokorozawa, Japan
[6] Tokyo Med & Dent Univ, Dept Gastrointestinal Surg, Tokyo, Japan
[7] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Colorectal Surg, Tokyo, Japan
[8] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan
[9] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, 1007 Shimonagakubo,Nagaizumi Cho, Shizuoka 4118777, Japan
来源
关键词
lateral lymph node dissection; lateral lymph node metastasis; local recurrence; rectal cancer; total mesorectal excision; PREOPERATIVE CHEMORADIOTHERAPY; MESORECTAL EXCISION; METASTASIS; BENEFIT; JAPAN;
D O I
10.1002/ags3.12789
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThis study aimed to evaluate the efficacy of lateral lymph node dissection (LLND) for rectal cancer by comparing the local control in patients with and without pathological lateral lymph node metastasis (LLNM).MethodsWe included 189 patients with rectal cancer who underwent total mesorectal excision and LLND at 13 institutions between 2017 and 2019. Patients with and without pathological LLNM were defined as the pLLNM (+) and (-) groups, respectively. Propensity score-matching helped to balance the basic characteristics of both groups. The incidences of local recurrence (LR) and lateral lymph node recurrence (LLNR) were compared between the groups.ResultsIn the entire cohort, 39 of the 189 patients had pathological LLNM. The 3-year LR and LLNR rates were 18.3% and 4.0% (p = 0.01) and 7.7% and 3.3% (p = 0.22) in the pLLNM (+) and (-) groups, respectively. After propensity score matching, the data from 62 patients were analyzed. No significant differences in LR or LLNR were observed between both groups. The 3-year LR and LLNR rates were 16.4% and 9.8% (p = 0.46) and 9.7% and 9.8% (p = 0.99) in the pLLNM (+) and (-) groups, respectively.ConclusionLLND would lead to comparable local control in the pLLNM (+) and (-) groups if the clinicopathological characteristics except for LLNM are similar. This study compared the incidence of local recurrence (LR) and lateral lymph node recurrence (LLNR) after total mesorectal excision and lateral lymph node dissection (LLND) between patients with and without pathological lateral lymph node metastasis (LLNM), using multicenter prospective data to assess the impact of LLND on the local control of rectal cancer. In the entire cohort, the 3-year LR and LLNR rates were 18.3% and 4.0% (p = 0.01) and 7.7% and 3.3% (p = 0.22) in the patients with and without pathological LLNM, while no significant differences in LR or LLNR were observed between both groups after propensity score matching. LLND would lead to comparable local control in the patients with and without pathological LLNM if the clinicopathological characteristics except for LLNM are similar.image
引用
收藏
页码:631 / 638
页数:8
相关论文
共 50 条
  • [31] Robotic Lateral Pelvic Lymph Node Dissection for Distal Rectal Cancer
    Chen, Tzu-Chun
    Liang, Jin-Tung
    DISEASES OF THE COLON & RECTUM, 2016, 59 (04) : 351 - +
  • [32] Risk factors and prognostic significance of postoperative complications following lateral pelvic lymph node dissection for rectal cancer: results of the multicenter lateral node study in China
    Zhou, Sicheng
    Tang, Jianqiang
    Mei, Shiwen
    Lou, Zheng
    Fu, Wei
    Feng, Bo
    Yang, Yingchi
    Sun, Yi
    Liu, Qian
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1150 - 1158
  • [33] Prognostic Factor of Lower Rectal Cancer with Lateral Pelvic Lymph Node Metastasis Treated with Lateral Lymph Node Dissection
    Yamauchi, S.
    Okazaki, S.
    Kikuchi, A.
    Ishiguro, M.
    Ishikawa, T.
    Uetake, H.
    Yasuno, M.
    Sugihara, K.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S93 - S93
  • [34] INITIAL EXPERIENCE WITH LATERAL PELVIC LYMPH NODE DISSECTION IN RECTAL CANCER-A PILOT STUDY
    Sinukumar, S.
    Saklani, A.
    GUT, 2015, 64 : A559 - A559
  • [35] Survival analysis after lateral lymph node dissection in rectal cancer: Necessity of nCRT for suspected lateral lymph node metastasis
    Liu, J.
    Jiang, P.
    Sun, Y.
    Zhang, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S109 - S109
  • [36] Laparoscopic lateral pelvic lymph node dissection for rectal cancer - a video vignette
    Karachun, A.
    Berlev, I.
    Petrov, A.
    Panaiotti, L.
    COLORECTAL DISEASE, 2018, 20 (04) : 358 - 358
  • [37] Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer
    Jia-Nan Chen
    Zheng Liu
    Zhi-Jie Wang
    Shi-Wen Mei
    Hai-Yu Shen
    Juan Li
    Wei Pei
    Zheng Wang
    Xi-Shan Wang
    Jun Yu
    Qian Liu
    World Journal of Gastroenterology, 2020, 26 (21) : 2877 - 2888
  • [38] Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer
    Chen, Jia-Nan
    Liu, Zheng
    Wang, Zhi-Jie
    Mei, Shi-Wen
    Shen, Hai-Yu
    Li, Juan
    Pei, Wei
    Wang, Zheng
    Wang, Xi-Shan
    Yu, Jun
    Liu, Qian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (21) : 2877 - 2888
  • [39] Laparoscopic treatment of rectal cancer and lateral pelvic lymph node dissection: are they obsolete?
    Toda, Shigeo
    Kuroyanagi, Hiroya
    Matoba, Shuichiro
    Hiramatsu, Kosuke
    Okazaki, Naoto
    Tate, Tomohiro
    Tomizawa, Kenji
    Hanaoka, Yutaka
    Moriyama, Jin
    MINERVA CHIRURGICA, 2018, 73 (06) : 558 - 573
  • [40] Correction to: Lateral lymph node dissection in advanced low rectal cancer treatment
    Jie Li
    Akio Shiomi
    International Journal of Colorectal Disease, 2021, 36 : 2373 - 2373